partnering

News

Astellas extends protein degrader drive with Cullgen deal

Astellas has become the latest big pharma to pledge big bucks to a smaller company working on protein degraders, paying $35 million upfront to partner with US start-up Cul

News

AstraZeneca inks $2bn Treg cell therapy deal with Quell

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which

R&D

ASCO 2023 preview: Prioritising the exploration of patient d...

The American Society of Clinical Oncology (ASCO) annual meeting is approaching and provides the ideal setting to connect

News

ElevateBio cooks up $401m round, garnished with a Novo deal

Cell and gene therapy specialist ElevateBio has taken the total fundraising since it launched five years ago to around $1.25 billion, with its latest $401 million round th

News

Foundation aims to level health access with digital tech

A new initiative called the Movement Health Foundation (MHF) has been launched with a pledge to encourage greater use of digital technologies to equalise access to healthc

News